Fate Therapeutics, Inc. Competitors

FATE 
$1.9
*  
unch
unch
Get FATE Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap ▼
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 85.14 -1.54 ▼ 15,653,904 $ 88.02
$ 84.45
$ 123.37
$ 81.89
7.8 122,702,065
Amgen Inc.
AMGN: NASDAQ-GS
$ 145.04 -4.87 ▼ 6,434,427 $ 149.385
$ 143.69
$ 181.81
$ 130.09
17.31 109,407,733
Biogen Inc.
BIIB: NASDAQ-GS
$ 263.86 -9.41 ▼ 2,838,430 $ 272.67
$ 258.46
$ 480.18
$ 254
17.23 58,815,186
Qiagen N.V.
QGEN: NASDAQ-GS
$ 21.05 -0.47 ▼ 4,470,820 $ 21.30
$ 20.50
$ 28.53
$ 21.26
47.84 4,901,008
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 31.85 -1.03 ▼ 3,308,330 $ 33.22
$ 30.08
$ 52.3299
$ 29.31
NE 4,442,470
Bio-Techne Corp
TECH: NASDAQ-GS
$ 87.53 2.73 ▲ 876,796 $ 87.57
$ 82.80
$ 114.56
$ 79.95
30.6 3,255,328
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 117.19 -4.42 ▼ 188,049 $ 123.67
$ 116.26
$ 144.2899
$ 67.14
37.09 3,109,051
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 35.99 -1.08 ▼ 2,315,563 $ 37.10
$ 34.90
$ 58.46
$ 32.67
NE 3,102,230
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 26.47 0.77 ▲ 2,711,182 $ 26.95
$ 24.60
$ 69.28
$ 22.37
NE 2,663,332
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 41.47 -5.72 ▼ 1,576,100 $ 46.86
$ 41
$ 89.84
$ 42.81
NE 1,832,186
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 47.73 -1.55 ▼ 1,559,919 $ 49.39
$ 46.68
$ 197.35
$ 37.40
NE 1,750,593
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 36.67 -0.61 ▼ 490,304 $ 37.64
$ 36.423
$ 43.63
$ 25.50
733.4 1,582,494
Novavax, Inc.
NVAX: NASDAQ-GS
$ 4.81 -0.07 ▼ 17,608,974 $ 4.86
$ 4.51
$ 15.01
$ 4.075
NE 1,298,017
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 7.90 -0.37 ▼ 2,028,431 $ 8.44
$ 7.75
$ 25.25
$ 7.49
NE 1,011,311
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 26.59 -1.41 ▼ 414,375 $ 28.27
$ 26.48
$ 50.86
$ 20
NE 983,910
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 5.07 -0.27 ▼ 3,623,934 $ 5.30
$ 5.055
$ 10.07
$ 4.72
NE 959,716
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 24.26 -2.08 ▼ 226,307 $ 25.83
$ 24.23
$ 44.759
$ 20.2601
NE 939,954
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 11.77 -0.65 ▼ 620,241 $ 12.47
$ 11.52
$ 25.56
$ 10.41
NE 812,095
Cellectis S.A.
CLLS: NASDAQ-GM
$ 20.41 -1.09 ▼ 106,973 $ 21.321
$ 20.121
$ 50
$ 19.80
NE 716,411
Repligen Corporation
RGEN: NASDAQ-GS
$ 21.04 -0.83 ▼ 352,470 $ 22.55
$ 20.97
$ 42.48
$ 20.54
77.93 693,142
NantKwest, Inc.
NK: NASDAQ-GS
$ 7.84 -0.66 ▼ 531,891 $ 8.56
$ 7.81
$ 38.48
$ 8.01
NE 636,765
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 25.14 -3.37 ▼ 285,549 $ 29.47
$ 25.14
$ 79.50
$ 24.5955
NE 621,285
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 14.32 1.08 ▲ 770,132 $ 15.28
$ 13.35
$ 38.10
$ 12.17
NE 556,948
Adaptimmune Therapeutics plc
ADAP: NASDAQ-GS
$ 7.12 -0.43 ▼ 125,594 $ 7.6799
$ 7.07
$ 21.57
$ 6.75
NE 503,989
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 17.16 -1.68 ▼ 184,656 $ 19.60
$ 16.95
$ 65.5599
$ 16.23
NE 491,308